 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 June 1999 | Volume 130 Issue 11 | Pages 883-890
Background: The incidence of esophageal and gastric cardia adenocarcinoma is, for unknown reasons, increasing dramatically. A weak and inconsistent association between body mass index (BMI) and adenocarcinoma of the esophagus and gastric cardia has been reported.
Objective: To reexamine the association between BMI and development of adenocarcinoma of the esophagus and gastric cardia.
Design: Nationwide, population-based case–control study.
Setting: Sweden, 1995 through 1997.
Patients: Patients younger than 80 years of age who had recently received a diagnosis were eligible. Comprehensive organization ensured rapid case ascertainment. Controls were randomly selected from the continuously updated population register. Interviews were conducted with 189 patients with adenocarcinoma of the esophagus and 262 patients with adenocarcinoma of the gastric cardia; for comparison, 167 patients with incident esophageal squamous-cell carcinoma and 820 controls were also interviewed.
Measurements: Odds ratios were determined from BMI and cancer case–control status. Odds ratios estimated the relative risk for the two adenocarcinomas studied and were calculated by multivariate logistic regression with adjustment for potential confounding factors.
Results: A strong dose-dependent relation existed between BMI and esophageal adenocarcinoma. The adjusted odds ratio was 7.6 (95% CI, 3.8 to 15.2) among persons in the highest BMI quartile compared with persons in the lowest. Obese persons (persons with a BMI > 30 kg/m2) had an odds ratio of 16.2 (CI, 6.3 to 41.4) compared with the leanest persons (persons with a BMI < 22 kg/m2). The odds ratio for patients with cardia adenocarcinoma was 2.3 (CI, 1.5 to 3.6) in those in the highest BMI quartile compared with those in the lowest BMI quartile and 4.3 (CI, 2.1 to 8.7) among obese persons. Esophageal squamous-cell carcinoma was not associated with BMI.
Conclusions: The association between BMI and esophageal adenocarcinoma is strong and is not explained by bias or confounding. The carcinogenic mechanism, however, remains to be clarified. The increasing prevalence of obesity in western countries could be important in understanding the increasing occurrence of this tumor.
Author and Article Information
From Karolinska Institutet, Stockholm, Sweden; and Uppsala University, Uppsala, Sweden.
Acknowledgments: The authors thank Leila Nyrén for coordination of the field work, Dr. Anders Lindgren for his review of all histopathologic material, and Dr. Wolfgang Kraaz for expert pathology guidance in the planning of the study and during the field work. They also thank the following physicians for acting as contact persons at the participating departments or providing invaluable input during the planning of this study: Bengt Åberg, Bo Ahlman, Örjan Ahrenstedt, Leif-Åke Åkesson, Stig-Olof Almgren, Per Almqvist, Nils-Axel Alsén, Mathias Ålund, Anders Alwmark, Christer Andersson, Lars Andréasson, Ulf Angerås, Åke Arwidi, Lars Backman, Björn Bäckstrand, Mikael Bech, Jan Bergman, Magnus Berne, Hlödur Bjarnasson, Anders Bjerkhed, Jan-Inge Björnberg, John Blomberg, Bernt Boeryd, Paul Boisen, Lars Boman, Anders Borgström, Mogens Bove, Mats Broberg, Stefan Cajander, Tora Cambell-Chiru, Hans Danielsson, Hilmi DeSai, Jan Dolata, Roger Edin, Kent Edin, Bengt Ekelund, Tom Ekstrand, Per Ekström, Lars-Krister Enander, Lennart Engström, Kerstin Erhart, Lars Eriksson, Thomas Eriksson, Sven-Börje Ewers, Jan Fagerberg, Mats Fagerberg, Anders Falk, Anders Faxén, Mats Fernström, Wolfgang Finkbeiner, Björn Fornander, Nils Forsby, Ulla Friberg, Kjell Furugård, Adel Gad, Ann Gawelin, Ole Grangaard, Lars Granström, Per Gullstrand, Olle Gunder, Peter Gunvén, Gunnar Gustafsson, Gustav Gustavsson, Hans Gustavsson, Sven Gustavsson, Göran Göransson, Mehmet Gözen, Tomas Hagerman, Ulf Haglund, Bengt Hallerbäck, Göran Hambreus, Erik Hammar, Ann Hammarlund, Lars-Erik Hammrström, Göran Hansson, Lennart Hardell, Lennart Hedenborg, Per Herlin, Lars-Erik Holmgren, Ivar Holmgren, Ulf Hyvönen, Hans-Olof Håkansson, Claes Höglund, Hans Högström, Gunnar Isaksson, Elisabeth Jansson, Roland Jansson, Pål-Henry Jeppsson, Karl-Erik Johansson, Sven Johansson, Leif Johansson, Leif Johansson, Göran Karlsson, Antii Kempas, Staffan Kinman, Ingvar Kjartanson, Gerhard Kjellén, Arne Kleberg, Per-Arne Kling, Jan Klos, Wieslava Krauze, Richard Kuylenstierna, Fredrik Kylberg, Anders Kylebäck, Peter Lannes, Lars-Göran Larsson, Sven Larsson, Carl-Erik Leijonmark, Freddi Lewin, Pontus Lidberg, Håkan Liljeholm, Tore Lind, Sten-Åke Lindahl, Jacob Lindhagen, Christer Lindholm, Karin Lindholm, Thomas Linné, Martin Ljungman, Otto Ljungberg, Mikael Ljungdahl, Thomas Lorenz, Bertil Lundberg, Kjell Lundberg, Sven Lundberg, Lars Lundell, Jan Lundgren, Lars Lundgren, Helge Lyckberg, Tord Magnusson, Jan Malina, Lennart Mannerberg, Joachim Mark, Ewa Mårtensson, Janusz Matusik, Lennart Mellbom, Claes Mercke, Anders Moberg, Hans Modig, Eva Munck-Wikland, Ingemar Näslund, Arthur Nathanson, Torben Navne, Anders Nihlberg, Klas Nilsell, Erik Nilsson, Kjell Nilsson, Lars Nilsson, Mats Nilsson, Ola Nilsson, Roland Nilsson, Arne Nordahl, Torgny Nordén, Bo Nordenskjöld, Stefan Öberg, Bengt Ohlander, Hans Öhman, Jan Öhman, Bo Ojen, Bengt Olsson, Håkan Olsson, Olle Olsson, Jan Oscarsson, Åke Öst, Görel Östberg, Jan Ovesen, Roland Pahlitzsch, Carl-Magnus Peterson, Karl-Iver Pettersson, Peter Pitkänen, Göran Rådberg, Ture Rådmark, Stig Ramel, Gunnar Rimsbäck, Björn Risberg, Jörgen Roed, Staffan Rosendahl, Sam Rotstein, Claes Rudberg, Lars Rudberg, Magnus Ruth, Rune Sandbu, Bengt Sandhammar, Ingemar Sandin, Björn Sandmark, José Santos, Runa Schedwin, Eric Secher, Ralf Segersvärd, Håkan Sellström, Charles Silseth, Göran Simert, Björn Sjöström, Johnny Sobin, Stefan Spinnell, Roger Stenling, Rolf Stjernman, Edit Stöckel, Dag Stockeld, Nils Stormby, Kaj Strid, Arild Stubberöd, Erik Svartholm, Conny Svensson, Jan-Olov Svensson, Anders Sylvan, Maria Sylvan, Kalev Teder, Kjell Thor, Lars Thulin, Orjan Tjernström, Torbjörn Tuvesson, Egil Tveit, Tadeusz Tyszkiewicz, Maciej Tytov, Sören Vallgren, Anders Victorin, Gunnar Wagenius, Torkel Wallin, Bruno Walther, Johan Wennerberg, Ingmar Wennström, Jens Wigermark, Olle Wihlborg, Bo Wikström, Erik Wilander, Bo Wilhelmsson, Roger Willén, and Mats Wirén.
Grant Support: By a grant from the National Cancer Institute (R01 CA57947-03), the Swedish Cancer Society, and the Dalarna Research Institute.
Requests for Reprints: Jesper Lagergren, Department of Medical Epidemiology, Karolinska Institutet, Box 281, S-171 77 Stockholm, Sweden; e-mail, Jesper.Lagergren{at}mep.ki.se.
Current Author Addresses: Drs. Lagergren and Nyrén: Department of Medical Epidemiology, Karolinska Institutet, Box 281, S-171 77 Stockholm, Sweden.
Dr. Bergström: Department of Statistics, Uppsala University, Box 513, S-751 20 Uppsala, Sweden. ARTICLE
Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia
This article has been cited by other articles:
|
|
 |
|
  J. A. Abrams Review: Chemoprevention of esophageal adenocarcinoma Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Sadeghi, C. J. Bain, N. Pandeya, P. M. Webb, A. C. Green, D. C. Whiteman, and for the Australian Cancer Study Aspirin, Nonsteroidal Anti-inflammatory Drugs, and the Risks of Cancers of the Esophagus Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1169 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Doecke, Z. Z. Zhao, M. S. Stark, A. C. Green, N. K. Hayward, G. W. Montgomery, P. M. Webb, D. C. Whiteman, and and for the Australian Cancer Study Single Nucleotide Polymorphisms in Obesity-Related Genes and the Risk of Esophageal Cancers Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 1007 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. El-Serag Role of obesity in GORD-related disorders Gut, March 1, 2008; 57(3): 281 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Corley, A. Kubo, and W. Zhao Abdominal Obesity and the Risk of Esophageal and Gastric Cardia Carcinomas Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 352 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D C Whiteman, S Sadeghi, N Pandeya, B M Smithers, D C Gotley, C J Bain, P M Webb, A C Green, and for the Australian Cancer Study Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus Gut, February 1, 2008; 57(2): 173 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sjodahl, C. Jia, L. Vatten, T. Nilsen, K. Hveem, and J. Lagergren Body Mass and Physical Activity and Risk of Gastric Cancer in a Population-Based Cohort Study in Norway Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 135 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Healy, A. M. Ryan, B. Gopinath, S. Rowley, P. J. Byrne, and J. V. Reynolds Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1284 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H H Merry, L. J Schouten, R A. Goldbohm, and P. A van den Brandt Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study Gut, November 1, 2007; 56(11): 1503 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. N. Scipione, A. C. Chang, A. Pickens, C. L. Lau, and M. B. Orringer Transhiatal Esophagectomy in the Profoundly Obese: Implications and Experience Ann. Thorac. Surg., August 1, 2007; 84(2): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lagergren Body measures in relation to gastro-oesophageal reflux Gut, June 1, 2007; 56(6): 741 - 742. [Full Text] [PDF]
|
|
|
|
|
|
D. A Corley, A. Kubo, and W. Zhao Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms Gut, June 1, 2007; 56(6): 756 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Chao, C. C. Maley, X. Wu, D. C. Farrow, P. C. Galipeau, C. A. Sanchez, T. G. Paulson, P. S. Rabinovitch, B. J. Reid, M. R. Spitz, et al. Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1935 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Ogunwobi, G. Mutungi, and I. L. P. Beales Leptin Stimulates Proliferation and Inhibits Apoptosis in Barrett's Esophageal Adenocarcinoma Cells by Cyclooxygenase-2-Dependent, Prostaglandin-E2-Mediated Transactivation of the Epidermal Growth Factor Receptor and c-Jun NH2-Terminal Kinase Activation Endocrinology, September 1, 2006; 147(9): 4505 - 4516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ye, R. Kumar, G. Bacova, J. Lagergren, K. Hemminki, and O. Nyren The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden Carcinogenesis, September 1, 2006; 27(9): 1835 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lagergren, P. Viklund, and C. Jansson Carbonated soft drinks and risk of esophageal adenocarcinoma: a population-based case-control study. J Natl Cancer Inst, August 16, 2006; 98(16): 1158 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Akre, L. Forssell, M. Kaijser, I. Noren-Nilsson, J. Lagergren, O. Nyren, and A. Ekbom Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case-control study. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 867 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kubo and D. A. Corley Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 872 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Schottenfeld and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin, March 1, 2006; 56(2): 69 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Jansson, N Plato, A L V Johansson, O Nyren, and J Lagergren Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma Occup. Environ. Med., February 1, 2006; 63(2): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. DeMeester Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment Ann. Surg. Oncol., January 1, 2006; 13(1): 12 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. D. Yumuk and P. F. Yumuk What Links Obesity to Cancer? Indoor and Built Environment, December 1, 2005; 14(6): 527 - 532. [Abstract] [PDF]
|
|
|
|
|
|
R. F. Souza and S. J. Spechler Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach CA Cancer J Clin, November 1, 2005; 55(6): 334 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kristal, P. L. Blount, J. M. Schenk, C. A. Sanchez, P. S. Rabinovitch, R. D. Odze, J. Standley, T. L. Vaughan, and B. J. Reid Low-Fat, High Fruit and Vegetable Diets and Weight Loss Do Not Affect Biomarkers of Cellular Proliferation in Barrett Esophagus Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2377 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hampel, N. S. Abraham, and H. B. El-Serag Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications Ann Intern Med, August 2, 2005; 143(3): 199 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Oh, Y. S. Yoon, and S.-A. Shin Effects of Excess Weight on Cancer Incidences Depending on Cancer Sites and Histologic Findings Among Men: Korea National Health Insurance Corporation Study J. Clin. Oncol., July 20, 2005; 23(21): 4742 - 4754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pohl and H. G. Welch RESPONSE: Re: The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence J Natl Cancer Inst, July 6, 2005; 97(13): 1014 - 1014. [Full Text] [PDF]
|
|
|
|
|
|
C. Jansson, A. L.V. Johansson, O. Nyren, and J. Lagergren Socioeconomic Factors and Risk of Esophageal Adenocarcinoma: A Nationwide Swedish Case-Control Study Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1754 - 1761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Yao, J. F. Tseng, S. Worah, K. R. Hess, P. F. Mansfield, C. H. Crane, I. I. Schnirer, S. Reddy, S. S. Chiang, A. Najam, et al. Clinicopathologic Behavior of Gastric Adenocarcinoma in Hispanic Patients: Analysis of a Single Institution's Experience Over 15 Years J. Clin. Oncol., May 1, 2005; 23(13): 3094 - 3103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Clements, D A Oleesky, S C Smith, H Wheatley, D A Hullin, T J Havard, and D J Bowrey A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus J. Clin. Pathol., May 1, 2005; 58(5): 490 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global Cancer Statistics, 2002 CA Cancer J Clin, March 1, 2005; 55(2): 74 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Lagergren Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut, March 1, 2005; 54(suppl_1): i1 - i5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pohl and H. G. Welch The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence J Natl Cancer Inst, January 19, 2005; 97(2): 142 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishikawa, J. Kitayama, S. Kazama, T. Hiramatsu, K. Hatano, and H. Nagawa Plasma Adiponectin and Gastric Cancer Clin. Cancer Res., January 15, 2005; 11(2): 466 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lindblad, W. Ye, C. Rubio, and J. Lagergren Estrogen and Risk of Gastric Cancer: A Protective Effect in a Nationwide Cohort Study of Patients with Prostate Cancer in Sweden Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2203 - 2207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Chang and D. A. Katzka Gastroesophageal Reflux Disease, Barrett Esophagus, and Esophageal Adenocarcinoma Arch Intern Med, July 26, 2004; 164(14): 1482 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. McManus, A. Olaru, and S. J. Meltzer Biomarkers of Esophageal Adenocarcinoma and Barrett's Esophagus Cancer Res., March 1, 2004; 64(5): 1561 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Engel, W.-H. Chow, T. L. Vaughan, M. D. Gammon, H. A. Risch, J. L. Stanford, J. B. Schoenberg, S. T. Mayne, R. Dubrow, H. Rotterdam, et al. Population Attributable Risks of Esophageal and Gastric Cancers J Natl Cancer Inst, September 17, 2003; 95(18): 1404 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Murray, B. Johnston, A. Lane, I. Harvey, J. Donovan, P. Nair, and R. Harvey Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project Int. J. Epidemiol., August 1, 2003; 32(4): 645 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Dixon and J Jankowski Commentary: The relation of obesity, reflux and its implications Int. J. Epidemiol., August 1, 2003; 32(4): 650 - 651. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nilsson, R. Johnsen, W. Ye, K. Hveem, and J. Lagergren Obesity and Estrogen as Risk Factors for Gastroesophageal Reflux Symptoms JAMA, July 2, 2003; 290(1): 66 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C U Nwokolo, D A Freshwater, P O'Hare, and H S Randeva Plasma ghrelin following cure of Helicobacter pylori Gut, May 1, 2003; 52(5): 637 - 640. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Spechler A 59-Year-Old Woman With Gastroesophageal Reflux Disease and Barrett Esophagus JAMA, January 22, 2003; 289(4): 466 - 475. [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Mayne and S. A. Navarro Diet, Obesity and Reflux in the Etiology of Adenocarcinomas of the Esophagus and Gastric Cardia in Humans J. Nutr., November 1, 2002; 132(11): 3467S - 3470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Chak, T Lee, M F Kinnard, W Brock, A Faulx, J Willis, G S Cooper, M V Sivak Jr, and K A B Goddard Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults Gut, September 1, 2002; 51(3): 323 - 328. [Abstract] [Full Text]
|
|
|
|
|
|
T. L. Vaughan, A. R. Kristal, P. L. Blount, D. S. Levine, P. C. Galipeau, L. J. Prevo, C. A. Sanchez, P. S. Rabinovitch, and B. J. Reid Nonsteroidal Anti-inflammatory Drug Use, Body Mass Index, and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W H Allum, S M Griffin, A Watson, and D Colin-Jones Guidelines for the management of oesophageal and gastric cancer Gut, June 1, 2002; 50 (2007): v1 - v23. [Full Text] [PDF]
|
|
|
|
|
|
N. Shaheen and D. F. Ransohoff Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review JAMA, April 17, 2002; 287(15): 1972 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H B El-Serag, A C Mason, N Petersen, and C R Key Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA Gut, March 1, 2002; 50(3): 368 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A Corley and P. A Buffler Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database Int. J. Epidemiol., December 1, 2001; 30(6): 1415 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Mayne, H. A. Risch, R. Dubrow, W.-H. Chow, M. D. Gammon, T. L. Vaughan, D. C. Farrow, J. B. Schoenberg, J. L. Stanford, H. Ahsan, et al. Nutrient Intake and Risk of Subtypes of Esophageal and Gastric Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1055 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Wajed, C. G. Streets, C. G. Bremner, and T. R. DeMeester Elevated Body Mass Disrupts the Barrier to Gastroesophageal Reflux Arch Surg, September 1, 2001; 136(9): 1014 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Glazer Long-term Pharmacotherapy of Obesity 2000: A Review of Efficacy and Safety Arch Intern Med, August 13, 2001; 161(15): 1814 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Conio, A J Cameron, Y Romero, C D Branch, C D Schleck, L J Burgart, A R Zinsmeister, L J Melton III, and G R Locke III Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota Gut, March 1, 2001; 48(3): 304 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|
Article
